To evaluate left atrial (LA) volume and function as assessed by strain and strain rate derived from 2D speckle tracking and their association with diastolic dysfunction (DD) in patients with diabetes mellitus (DM).
Introduction
Diastolic heart failure with preserved left ventricular (LV) systolic function is a well-recognized entity. 1 The presence of type 2 diabetes mellitus (DM) in general has a significant association with the development of diastolic dysfunction (DD) and subsequent heart failure. 2 Moreover, the prevalence of LV DD in patients with DM is significantly greater than that in the general population and is reported between 43 and 75%. 3, 4 The 'booster pump' effect of left atrial (LA) contraction in the late diastole contributes up to 30% of cardiac output 5 and is of particular importance in patients with LV dysfunction or heart failure. Additionally, LA enlargement and dysfunction have been considered surrogate markers of the chronicity and severity of DD. 6 Thus, the evaluation of LA function in patients with DM is important as it may reflect underlying DD while at the same time estimating atrial contractile function contribution to cardiac output. Structural and functional changes in the left atrium have been previously demonstrated in patients with DM albeit in small numbers. 7, 8 Hypertension (HT), a common coexistent cardiac risk factor is also associated with altered LA size and function.
9 † Institution of study: Liverpool Hospital NSW and Princess Alexandra Hospital Brisbane.
It has been established that tissue Doppler-derived strain imaging can assess LA function in varying conditions with LA dysfunction. 10 -13 However, tissue Doppler-derived strain measurements are time intensive and limited by angle dependency. 14 LA strain can also be derived from two-dimensional (2D) images by speckle tracking which is a semi-automated process not limited by angle dependency. 15 The aim of the present study was to (i) evaluate the LA size in patients with type 2 DM and evaluate the independent effect of DM on the LA size compared with controls and those with HT alone, (ii) evaluate LA function by 2D speckle tracking-derived strain compared with a group of age-matched normal subjects and those with HT alone and (iii) to evaluate the LA volume change with varying grades of DD in patients with DM. We additionally hypothesized that LA dysfunction would be present in patients with DM due to the increased prevalence of DD in DM with increasing LA size with worsening grades of diastolic function.
Methods

Study population
Seventy-six subjects with type 2 DM were recruited from the Princess Alexandra Hospital, Brisbane. Patients were identified from the cardiology and endocrinology department; 43 of the 76 patients had coexistent mild HT (mean systolic BP: 140 + 14 mmHg and mean diastolic BP: 81 + 8 mmHg). Three patients were excluded from the final analysis due to suboptimal image quality. All recruited patients were on therapy for DM including diet control, oral hypoglycemic agent or insulin. Study approval was obtained from the human research and ethics committee and all recruited patients provided written consent. A comprehensive transthoracic echocardiogram was performed in all recruited patients. There was no ECG or echocardiographic evidence of coronary artery disease and all patients underwent a stress echocardiogram to rule out latent ischaemia. Patients were excluded from the study, if they had greater than mild mitral or aortic regurgitation or aortic stenosis or any degree of mitral stenosis. None of the recruited patients or controls had any history of congestive heart failure and all patients had a normal LV ejection fraction.
Age-matched 'normal' subjects were identified from a departmental database at Liverpool Hospital, Sydney. These healthy volunteers were recruited from the community and were carefully screened for a history of cardiovascular, peripheral vascular or cerebrovascular disease and for the presence of cardiovascular risk factors including HT, DM, hypercholesterolemia. They had no abnormal findings on routine physical examination, were normotensive and had a normal ECG and echocardiogram and were not receiving any cardio-active medications. Thirty patients with mild HT were identified from a departmental database and recruited as a comparator group. These subjects had systolic pressure .140 but ,160 mmHg and diastolic pressure .90 but ,100 mmHg. Blood pressure recordings were performed on three separate times and all previously recorded measurements were ,160/100 mmHg. The HT group had no other associated cardiac risk factor. A subgroup comparison of the 30 patients with DM alone was performed with the 30 patients with HT.
Conventional echocardiography
A commercially available ultrasound machine (Vivid 7, General Electric Medical Systems, Milwaukee, WI, USA) equipped with a 2.5-MHz variable frequency transducer was used for echocardiographic evaluation. 2D and colour Doppler images were obtained from standard echocardiographic views, including parasternal and apical views with patients and subjects in a left lateral decubitus position. Tissue Doppler imaging was used to obtain systolic and diastolic velocities from the mitral annulus. 2D images were acquired at high frame rates ( 70 fps) and stored digitally for offline strain analysis.
Left ventricular measurements
Left ventricular wall thickness, LV end diastolic (LVEDD) and end systolic (LVESD) diameters were measured using M mode from the parasternal long axis view. LV end systolic and end diastolic volumes were measured by Simpson's biplane method from the apical four-and two-chamber views and the LV ejection fraction was calculated. LV mass index (LVMI) was calculated using the diastolic measurements of left ventricular internal diameter, interventricular septal thickness and posterior wall thickness. 16 Transmitral flow velocities were obtained by placing a pulsed wave Doppler sample volume at the mitral leaflet tips in the apical four-chamber view. Peak velocity in early (E-wave) and late diastole (A-wave) and E-wave deceleration time (DT) were measured and E/A ratio calculated. Pulsed wave Doppler tissue imaging was used to measure the peak velocity in early (E ′ ) and late (A ′ ) diastole with the sample volume placed at the septal and lateral annulus. 17 An average of the septal and lateral E ′ velocities were calculated as per ASE recommendation. 18 The E/E ′ ratio was calculated as an estimate of LV diastolic pressure. 17 
Diastolic classification
LV diastolic function was classified as normal (DT ¼ 160-240 ms, E/A ratio ¼ 0. 
Traditional LA measurements
The LA volume was measured using the prolate ellipse method 20 incorporating LA diameters from three planes; the maximum LA volume was indexed to body surface area (LAVI). Atrial function was estimated using traditional measures including the peak transmitral A-wave velocity, A-wave velocity time integral (VTI) and the atrial fraction (A-wave VTI/total mitral inflow VTI).
An average of three measurements was used for the final analysis.
2D speckle tracking strain imaging
Of the 76 recruited patients with DM, strain measurements could only be obtained in 73 (96%). 2D speckle tracking strain and strain rate (SR) analysis, using customized computer software (EchoPAC, Vingmed, General Electric, Horten, Norway) was performed using a zoomed view of the LA from the apical four chamber acquired at 70 fps. The LA endocardium was manually drawn in end systole; thereafter the endocardial borders were automatically tracked by the computer software throughout the cardiac cycle. The LA myocardial width was adjusted by varying the thickness of the ROI applied to track the LA borders. The LA myocardium was divided into six segments (basal, mid-, and apical segments of the septum and lateral wall, respectively). The software displayed peak longitudinal systolic strain (S) ( Figure 1A ), systolic (S-SR), early diastolic (E-SR), and late diastolic (A-SR) atrial strain rates for each of the six individual segments ( Figure 1B) .
LA S-SR is measured during the passive stretching of the LA during left ventricular systole and is thus an index of LA reservoir function. 21 Similarly, the E-SR and A-SR have been used as indices of LA conduit and LA contractile function, respectively. 22 Data presented are an average of three measurements.
Statistical analysis
All values are expressed as mean + SD. An independent samples 't'-test analysis was performed to evaluate the differences between the DM group and normal controls. Differences among those with DM alone (n ¼ 30), HT group and normal controls were examined by one-way ANOVA with post hoc Bonferroni analysis. Data were considered significant if P , 0.05. Spearman's rank correlation was used to assess the correlation between LAVI and global strain with grades of DD. Differences among the DM group based on diastolic function grade were examined by one-way ANOVA with post hoc Bonferroni analysis. Data were considered significant if P , 0.05. Data were analysed using SPSS (version 17.0, SPSS, Inc., Chicago, Illinois). A logistic regression analysis was performed using SAS 9.2 (Cary, NC, USA) to examine the relationship between LAVI and global strain with other covariates including age, diastolic grade, E/E ′ ratio, LVMI, the presence of HT and patient group (i.e. the presence of diabetes).
Results
A total of 73 DM patients and an equal number of age-matched controls were included in the final analysis. Demographic data of the DM group vs. controls are presented in Table 2 . The HT group was older, and not surprisingly had a higher systolic and diastolic blood pressure. The DM group weighed more than both healthy controls and HT group and consequently had a higher BSA.
LV systolic and diastolic parameters
LV end diastolic and end systolic diameters were similar in the DM group and controls. Although LV ejection fraction was in the normal range in both groups, the LV ejection fraction was higher in the DM group ( Table 1 ). The LV mass was higher in the DM group but when indexed to BSA (LVMI), no statistically significant differences were observed between groups ( Table 1) . As expected, traditional LV diastolic function parameters including peak E and A velocities, E/A ratio, DT, and E/E ′ were abnormal in patients with DM compared with controls (Table 1) .
Comparison between the subgroup of patients with DM alone vs. HT group and normal controls demonstrated LV wall thickness was increased in the HT group, with a significantly greater indexed LV mass. LVEF was in the normal range in the three groups with LVEF higher than controls in both the DM and HT groups. Traditional LV diastolic parameters were altered in the DM and HT groups ( Table 2) .
LA volume and function
The LA maximum volume and LAVI were significantly larger in the DM group than that in normal controls ( Table 1) . The peak A velocity was higher in the DM group. Although the A-wave VTI was similar, a higher atrial fraction as well as the A ′ velocity was observed in the DM group (Table 1 ). In the subgroup comparison, LAVI increased only in the DM group compared with both the groups with HT and normal controls. Parameters of atrial function including A-wave VTI, atrial fraction, and A ′ velocity were similar in the DM and HT groups.
Atrial strain measurements
Peak positive 2D strain was reduced in the DM group across all six segments (Table 3) . Global strain, derived as an average of six segments, was 22.5 + 8.7% in the diabetic group vs. 30.6 + 8.3% in the normal control group (P value , 0.0001; Table 3 ). Patients in the DM group had altered phasic LA function with impaired LA reservoir and conduit functions as indicated by a reduction in LA S-SR and LA E-SR, respectively. LA A-SR, an indicator of LA contractile function, was also reduced in the DM group (Table 3 ). In the subgroup comparison between the DM and HT groups vs. controls, LA strain was similar in the DM and HT groups with a significant reduction in S-SR, E-SR, and A-SR in the DM group (Table 4) .
Determinants of LAVI in DM
We examined the relationship between LAVI to age, group (DM and control groups), E/E ′ ratio, LVMI, diastolic grade, LVEF, and presence of HT to determine univariate predictors of LAVI. These predictors were entered into a logistic regression analysis (Table 5 ). In this model, a statistically significant relationship was only present between LAVI and presence of diabetes (P , 0.0001), adjusting for all other covariates including the diastolic grade and presence of HT. The logistic regression model LA volume and dysfunction in the DM group based on severity of diastolic dysfunction
A weak correlation was observed between varying grades of DD and LAVI by Spearman's rank correlation (r ¼ 0.439, P , 0.0001). Similarly, a weak negative correlation was seen with global strain and grades of DD (r ¼ 2 0.316, P , 0.0001). A subgroup analysis for varying grades of LVDD was performed within the DM group using ANOVA with post hoc Bonferoni correction. However, there was no significant difference in LAVI, global strain or systolic or diastolic SR measurements among varying grades of diastolic function in the DM group (Table 6 ).
Discussion
Our study confirms the high prevalence of DD in DM, with 78% of patients with DM manifesting some diastolic abnormality. We deliberately included a significant proportion with coexistent mild HT as would be seen in the routine clinical scenario. We demonstrated LA enlargement in patients with DM that was independent of the effects of HT and grade of DD. There was associated atrial dysfunction that was also independent of the grades of DD in this group. The subgroup analysis performed between patients with DM alone and a group with HT additionally demonstrated a significantly larger LAVI in the DM group.
LA size
LA enlargement has previously been reported in subjects with DM. Poulsen et al.
1 demonstrated moderate-to-severe LA enlargement (LA volume index . 32 ml/m 2 ) in a third of their study population comprising 305 subjects with DM. However, only 40% had abnormal diastolic function in their study group. In our study population, two-thirds of the DM group had DD and more than half had associated HT. LA enlargement is a surrogate marker of LVDD 6 and given the high prevalence of DD in the DM group is a likely contributor. LAVI was larger in the patients with DM alone than those in HT.
In the current DM group, 16 patients were classified as having 'normal' diastolic function; interestingly LA enlargement was present in this group as well. Further, no significant difference was noted in the LA volume across the three grades of diastolic function. These observations are similar to that reported by Jarnert. 8 In that study, mean LAVI was increased even in the subgroup with normal diastolic function. Despite a significant increase in the maximum LAV with grades of DD, LAVI failed to demonstrate any significant difference between grades of DD. This suggests that an altered LV diastolic function in DM only contributes in part to observed LA changes. Thus, it is likely that an independent atrial cardiomyopathy associated with DM may be a likely contributor to LA enlargement.
LA function
Echocardiographic parameters to measure LA function are still evolving. Global and phasic LA function using 2D strain and SR parameters are feasible and have been used to assess LA dysfunction.
14,15
2-D speckle tracking-derived strain analysis was demonstrated to be a feasible method to assess LA longitudinal strain in healthy subjects. 23 2D strain measurements are semi-automated with less variability compared with tissue Doppler-derived strain. 24 In the current study, both global and segmental systolic strains were significantly reduced in the DM group as previously demonstrated using TDI 7 and velocity vector imaging (VVI)-derived strain. 8 Global strain was also similarly reduced in the group with alter LA compliance with a reduction in reservoir function as observed by the reduced S-SR. E-SR was reduced and is the reflection of altered LV relaxation with a consequent reduction in the LA conduit function. Thus, it is likely that atrial fibrosis is greater in the DM as both S-SR and E-SR were higher in the HT group.
Traditional parameters including transmitral A velocity, atrial fraction, and A ′ velocity were increased in subjects with DM as well as in the group with HT. These indicate a compensatory increase in blood flow in late diastole given the reduced early diastolic filling consequent to LV DD. The increased LA volume would additionally result in increased flow during atrial contraction. However the A-SR was decreased, suggesting altered intrinsic LA function with a reduction in atrial deformation during its contractile phase even compared with the HT group.
LA changes and grades of diastolic dysfunction
LA enlargement was present in the DM group even in patients with normal diastolic function; only a weak correlation was observed between LAVI and varying diastolic grades. 
Study limitation
The sample size of the study is modest and our findings need to be validated in a larger population. A significant number of DM patients had coexistent mild HT; however, a subgroup comparison between patients with DM alone to the group with mild HT was performed to examine these differences. Failure to observe differences in the LA volume and function between varying grades of DD may represent a beta error. The normal controls did not undergo a stress test or stress echocardiogram to rule out latent ischemia. However, none of the controls had significant cardiac risk factors.
The use of another imaging modality such as magnetic resonance imaging to assess the LA size and function was considered beyond the scope of the present study.
2D speckle tracking strain imaging is reliant on image quality and frame rate, even though this is angle independent. Patients with poor imaging windows (n ¼ 3) were excluded based on poor image quality as measurements could not be adequately interpreted. Hence, the results are representative of the population where 2D speckle tracking is possible.
Left atrial volume and function may be affected by patient medication especially beta blockers. Only three patients in the DM group and two in the HT group were on beta-blockers. Renal function too could alter left atrial parameters; however, in our diabetic patient group, only three patients had mild renal impairment (creatinine of 168, 130, and 110 mmol/L). Given the small number of patients with renal impairment and relatively small numbers on betablockers, performing subgroup analysis would not be possible.
Conclusion
Diabetes causes LA enlargement that is independent of the effects of coexistent HT and DD. Thus, LA enlargement with associated LA dysfunction is likely due to the combination of DD and a coexistent atrial myopathy consequent to DM. Longitudinal studies including larger patient numbers are required to ascertain if parameters of atrial size and function may predict future adverse cardiovascular outcomes in a diabetic population.
